Market Research Logo

Post-Cardiac Arrest Syndrome (PCAS) - Epidemiology Forecast to 2027

DelveInsight’s ‘Post-Cardiac Arrest Syndrome (PCAS) - Epidemiology Forecast to 2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Post-Cardiac Arrest Syndrome in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geography Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2027

Post-Cardiac Arrest Syndrome Epidemiology

The Post-Cardiac Arrest Syndrome epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. The epidemiology data for PCAS are studied through all possible division to give a better understanding of the Disease scenario in 7MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey report, and views of key opinion leaders.

Post-Cardiac Arrest Syndrome Epidemiology Segmentation

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (total Diagnosed Incident cases, Resuscitation of Out-Of-Hospital Sudden Cardiac Arrest (OHSCA) Cases, Resuscitation of In-Hospital Sudden Cardiac Arrest (IHSCA) cases), scenario of PCAS in the seven major markets covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.
The DelveInsight report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
According to DelveInsight, the total diagnosed incident population of Post-Cardiac Arrest Syndrome in the 7 major markets was found to be 1,150,165 in 2016.

Report Scope

• The report covers a detailed overview of Post-Cardiac Arrest Syndrome explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The report provides insight about the historical and forecasted patient pool of Post Cardiac Arrest Syndrome in the 7MM covering the United States, EU5 (Germany, Spain, France, Italy, UK) and Japan
• The Report assesses the disease risk and burden and highlights the unmet needs of the disease
• The Report helps to recognize the growth opportunities in the 7MM with respect to the patient population
• The report provides the segmentation of the disease epidemiology by Resuscitation of OHSCA and IHSCA Cases i.e., ROSC Cases, ROSC Comatose Cases PCAS in seven major markets

Key strengths

• 10 Year Forecast of Post-Cardiac Arrest Syndrome epidemiology
• 7MM Coverage
• Total Diagnosed Incident Cases of PCAS
• Cases according to epidemiology segmentation: Resuscitation of Out-Of-Hospital Sudden Cardiac Arrest (OHSCA) Cases and Resuscitation of In-Hospital Sudden Cardiac Arrest (IHSCA) Cases

Key assessments

• Patient Segmentation
• Disease Risk & Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population


1. Key Insights
2. PCAS Market Overview at a Glance
2.1. Market Share (%) Distribution of PCAS in 2017
2.2. Market Share (%) Distribution of PCAS in 2027
3. Disease Overview: PCAS
3.1. Introduction
3.2. Phases of the PCAS
3.3. Causes of Sudden Cardiac Arrest
3.4. Risk Factors
3.5. Pathophysiology of PCAS
3.6. Molecular and genetic basis of sudden cardiac death
3.7. Biomarkers
3.8. Diagnosis
3.8.1. Glasgow Coma Scale
3.8.2. Prognosis for Cardiac Arrest Survivors
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. 7MM Total Diagnosed Incident Patient Population of Sudden Cardiac Arrest (SCA)
5. Country Wise-Epidemiology of PCAS
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Diagnosed Incident Cases of Sudden Cardiac Arrest in the United States
5.1.3. Resuscitation of Out-Of-Hospital Sudden Cardiac Arrest (IHSCA) Cases in the US
5.1.4. Resuscitation of In-Hospital Sudden Cardiac Arrest (IHSCA) Cases in the US
5.2. Germany
5.2.1. Assumptions and Rationale
5.2.2. Diagnosed Incident Cases of Sudden Cardiac Arrest in the Germany
5.2.3. Resuscitation of Out-Of-Hospital Sudden Cardiac Arrest (IHSCA) Cases in Germany
5.2.4. Resuscitation of In-Hospital Sudden Cardiac Arrest (IHSCA) Cases in Germany
5.3. France
5.3.1. Assumptions and Rationale
5.3.2. Diagnosed Incident Cases of Sudden Cardiac Arrest in France
5.3.3. Resuscitation of Out-Of-Hospital Sudden Cardiac Arrest (IHSCA) Cases in France
5.3.4. Resuscitation of In-Hospital Sudden Cardiac Arrest (IHSCA) Cases in France
5.4. Italy
5.4.1. Assumptions and Rationale
5.4.2. Diagnosed Incident Cases of Sudden Cardiac Arrest in Italy
5.4.3. Resuscitation of Out-Of-Hospital Sudden Cardiac Arrest (IHSCA) Cases in Italy
5.4.4. Resuscitation of In-Hospital Sudden Cardiac Arrest (IHSCA) Cases in Italy
5.5. Spain
5.5.1. Assumptions and Rationale
5.5.2. Diagnosed Incident Cases of Sudden Cardiac Arrest in Spain
5.5.3. Resuscitation of Out-Of-Hospital Sudden Cardiac Arrest (IHSCA) Cases in Spain
5.5.4. Resuscitation of In-Hospital Sudden Cardiac Arrest (IHSCA) Cases in Spain
5.6. United Kingdom
5.6.1. Assumptions and Rationale
5.6.2. Diagnosed Incident Cases of Sudden Cardiac Arrest in the United Kingdom
5.6.3. Resuscitation of Out-Of-Hospital Sudden Cardiac Arrest (IHSCA) Cases in the United Kingdom
5.6.4. Resuscitation of In-Hospital Sudden Cardiac Arrest (IHSCA) Cases in the United Kingdom
5.7. Japan
5.7.1. Assumptions and Rationale
5.7.2. Diagnosed Incident Cases of Sudden Cardiac Arrest in Japan
5.7.3. Resuscitation of Out-Of-Hospital Sudden Cardiac Arrest (IHSCA) Cases in Japan
5.7.4. Resuscitation of In-Hospital Sudden Cardiac Arrest (IHSCA) Cases in Japan
6. Market Drivers
7. Market Barriers
8. Appendix
8.1. Report Methodology
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
List of Tables and Figures
Table 1: PCAS: Pathophysiology, Clinical Manifestations, and Potential Treatments
Table 2: Diagnosed Incident Patient Population of SCA in 7MM (2016-2027)
Table 3: Diagnosed Incident Cases of SCA in the US (2016-2027)
Table 4: Resuscitation of OHSCA Cases in the US (2016-2027)
Table 5: Resuscitation of IHSCA Cases in the US (2016-2027)
Table 6: Diagnosed Incident Cases of SCA in Germany (2016-2027)
Table 7: Resuscitation of OHSCA Cases in Germany (2016-2027)
Table 8: Resuscitation of IHSCA Cases in Germany (2016-2027)
Table 9: Diagnosed Incident Cases of SCA in France (2016-2027)
Table 10: Resuscitation of OHSCA Cases in France (2016-2027)
Table 11: Resuscitation of IHSCA Cases in France (2016-2027)
Table 12: Diagnosed Incident Cases of SCA in Italy (2016-2027)
Table 13: Resuscitation of OHSCA Cases in Italy (2016-2027)
Table 14: Resuscitation of IHSCA Cases in Italy (2016-2027)
Table 15: Diagnosed Incident Cases of SCA in Spain (2016-2027)
Table 16: Resuscitation of OHSCA Cases in Spain (2016-2027)
Table 17: Resuscitation of IHSCA Cases in Spain (2016-2027)
Table 18: Diagnosed Incident Cases of SCA in the UK (2016-2027)
Table 19: Resuscitation of OHSCA Cases in the UK (2016-2027)
Table 20: Resuscitation of IHSCA Cases in the UK (2016-2027)
Table 21: Diagnosed Incident Cases of SCA in Japan (2016-2027)
Table 22: Resuscitation of OHSCA Cases in Japan (2016-2027)
Table 23: Resuscitation of IHSCA Cases in Japan (2016-2027)
Figure 1: Phases of PCAS
Figure 2: Pathophysiology of PCAS
Figure 3: Diagnosed Incident Patient Population of SCA in 7MM (2016-2027)
Figure 4: Diagnosed Incident Cases of SCA in the US (2016-2027)
Figure 5: Resuscitation of OHSCA Cases in the US (2016-2027)
Figure 6: Resuscitation of IHSCA Cases in the US (2016-2027)
Figure 7: Diagnosed Incident Cases of SCA in Germany (2016-2027)
Figure 8: Resuscitation of OHSCA Cases in Germany (2016-2027)
Figure 9: Resuscitation of IHSCA Cases in Germany (2016-2027)
Figure 10: Diagnosed Incident Cases of SCA in France (2016-2027)
Figure 11: Resuscitation of OHSCA Cases in France (2016-2027)
Figure 12: Resuscitation of IHSCA Cases in France (2016-2027)
Figure 13: Diagnosed Incident Cases of SCA in Italy (2016-2027)
Figure 14: Resuscitation of OHSCA Cases in Italy (2016-2027)
Figure 15: Resuscitation of IHSCA Cases in Italy (2016-2027)
Figure 16: Diagnosed Incident Cases of SCA in Spain (2016-2027)
Figure 17: Resuscitation of OHSCA Cases in Spain (2016-2027)
Figure 18: Resuscitation of IHSCA Cases in Spain (2016-2027)
Figure 19: Diagnosed Incident Cases of SCA in the UK (2016-2027)
Figure 20: Resuscitation of OHSCA Cases in the UK (2016-2027)
Figure 21: Resuscitation of IHSCA Cases in the UK (2016-2027)
Figure 22: Diagnosed Incident Cases of SCA in Japan (2016-2027)
Figure 23: Resuscitation of OHSCA Cases in Japan (2016-2027)
Figure 24: Resuscitation of IHSCA Cases in Japan (2016-2027)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report